Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-04

Clinical Trial Update: Calcitonin in the Treatment of Fibromyalgia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating calcitonin for fibromyalgia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitonin (calcitonin)

Snippet

Sponsor: Unidad de Investigacion en Enfermedades Cronico-Degenerativas | Conditions: Fibromyalgia | Phase 4 | Status: WITHDRAWN